![PDF] Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece by G Gourzoulidis, C. Tzanetakos, Ioannis Ioannidis, Apostolos Tsapas, Georgia PDF] Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece by G Gourzoulidis, C. Tzanetakos, Ioannis Ioannidis, Apostolos Tsapas, Georgia](https://og.oa.mg/Budget%20Impact%20Analysis%20of%20Empagliflozin%20For%20The%20Treatment%20of%20Patients%20With%20Type%202%20Diabetes%20Mellitus%20At%20Increased%20Cardiovascular%20Risk%20In%20Greece.png?author=%20G%20Gourzoulidis,%20C.%20Tzanetakos,%20Ioannis%20Ioannidis,%20Apostolos%20Tsapas,%20Georgia%20Kourlaba,%20G.%20Papageorgiou,%20Nikolaos%20Maniadakis)
PDF] Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece by G Gourzoulidis, C. Tzanetakos, Ioannis Ioannidis, Apostolos Tsapas, Georgia
Ioannis Maniadakis email address & phone number | QUALCO VP of New Ventures contact information - RocketReach
![Ioannis Maniadakis email address & phone number | QUALCO VP of New Ventures contact information - RocketReach Ioannis Maniadakis email address & phone number | QUALCO VP of New Ventures contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/spyros-retzekas-business-development-executive-director-qualco-08078e09.jpg)